Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster

Pharmacogenetics

Volumn 6, Issue 1, 1996, Pages 55-66

  Ferguson, Ronald J ^a,b,c   Doll, Mark A ^a   Rustan, Timothy D ^a   Hein, David W ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

acetylation polymorphism; N acetyltransferase; NAT2; Syrian hamster

Indexed keywords

2 FLUORENYLAMINE; 4 AMINOBENZOIC ACID; ACYLTRANSFERASE; AMIDE; AMINE; DNA; ISOENZYME; ISONIAZID; PROTEIN;

ACETYLATION; ACETYLATOR PHENOTYPE; ALLELE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; METABOLIC ACTIVATION; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SYRIAN HAMSTER;

ACETYLATION; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CLONING, MOLECULAR; CRICETINAE; DNA PRIMERS; ENZYME STABILITY; ISOENZYMES; KINETICS; MESOCRICETUS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS;

ANIMALIA; CRICETINAE; ESCHERICHIA COLI; MESOCRICETUS AURATUS;

EID: 0029869584     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199602000-00004     Document Type: Article

References (52)

1. Abu-Zeid M, Nagata K, Miyata M, Ozawa S, Fukuhara M, Yamazoe Y, Kato R. An arylamine N-acetyltransferase (AT-1) from Syrian golden hamster liver: cloning, complete nucleotide sequencing, and expression in mammalian cells. Molec Carcinogenesis 1991: 4, 81-88.
2. Blum M, Grant DM, Demierre A, Meyer UA. N-acetylation pharmacogenetics: A gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits. Proc Natl Acad Sci USA 1989: 86, 9554-9557.
3. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal location, and functional expression. DNA Cell Biol 1990a: 9, 195-203.
4. Blum M, Heim M, Meyer UA. Nucleotide sequence of rabbit NAT1 encoding monomorphic arylamine N-acetyltransferase. Nucl Acids Res 1990b: 5287.
5. Blum M, Heim M, Meyer UA. Nucleotide sequence of rabbit NAT2 encoding polymorphic liver arylamine N-acetyltransferase. Nucl Acids Res 1990c: 5295.
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochern 1976: 72, 248-254.
7. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984: 81, 1991-1995.
8. Dixon M, Webb EC. Enzymes, 3rd edition. New York: Academic Press 1979.
9. Doll MA, Hein DW. Cloning, sequencing, and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 1995: 5, 247-251.
10. Doll MA, Feng Y, Hein DW. Cloning, sequencing, and functional characterization of NAT2*21B: A second polymorphic N-acetyltransferase gene identified in a slow acetylator rat. Proc VII Inter Cong Toxicol 1995: 46-p -21.
11. Evans DAP. N-acetyltransferase. Pharmacol Ther 1989: 42, 157-234.
12. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983: 132, 6-13.
13. Ferguson RJ, Doll MA, Baumstark BR, Hein DW. Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters. Gene 1994a: 140, 247-249.
14. Ferguson RJ, Doll MA, Rustan TD, Baumstark BR, Hein DW. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli. Pharmacogenetics 1994b: 4, 82-90.
15. s) acetylator Syrian hamster polymorphic N-acetyltransferase in E. coli. Proc Am Assoc Cancer Res 1994c: 35, 133.
16. Grant DM, Lottspeich F, Meyer UA. Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver. FEBS Lett 1989: 244, 203-207.
17. Grant DM, Blum M, Beer M, Meyer UA. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 1991: 39, 184-191.
18. Hanna PE. N-Acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. Adv Pharmacol 1994: 27, 401-430.
19. Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 1988: 948, 37-66.
20. Hein DW. A new model for toxic risk assessments: construction of homozygous rapid and slow acetylator congenic hamster lines. Toxicol Meth 1991: 1, 44-52.
21. Hein DW, Hirata M, Glowinski IB, Weber WW. Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver. J Pharmacol Exp Ther 1982a: 220, 1-7.
22. Hein DW, Omichinski JG, Brewer JA, Weber WW. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J Pharmacol Exp Ther 1982b: 220, 8-15.
23. Hein DW, Kirlin WG, Ferguson RJ, Weber WW. Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster. J Pharmacol Exp Ther 1985a: 233, 584-587.
24. Hein DW, Kirlin WG, Ferguson RJ, Weber WW. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster. J Pharmacol Exp Ther 1985b: 234, 358-364.
25. Hein DW, Flammang TJ, Kirlin WG, Trinidad A, Ogolla F. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase. Carcinogenesis 1987: 8, 1767-1774.
26. Hein DW, Trinidad A, Yerokun T, Ferguson RJ, Kirlin WG, Weber WW. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxyarylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A. B6 and B6. A congenic inbred mouse. Drug Metab Dispos 1988: 16, 341-347.
27. Hein DW, Rustan TD, Bucher KD, Martin WJ, Furman EJ. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab Dispos 1991: 19, 933-937.
28. Hein DW, Doll MA, Gray K, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res 1993a: 53, 509-514.
29. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and NAT2 acetyltransferases. Carcinogenesis 1993b: 14, 1633-1638.
30. Hein DW, Doll MA, Rustan TD, Gray K, Ferguson RJ, Feng Y. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens. Toxicol Appl Pharmacol 1994: 124, 16-24.
31. Huynh TV, Young RA, Davis RW. Constructing and screening cDNA libraries in λgt10 and λgt11, in: Glover D, ed. DNA Cloning: A Practical Approach. Oxford: IRL Press, 1984: 49.
32. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP. Polymorphisms for aromatic amine metabolism in humans - relevance for human Carcinogenesis. Env Health Persp 1992: 98, 69-74.
33. Land SJ, Jones RF, King CM. Biochemical and genetic analysis of two acetyltransferases from hamster tissues that can metabolize aromatic amine derivatives. Carcinogenesis 1994: 15, 1585-1595.
34. MacFerrin KD, Terranova MP, Schreiber SL, Verdine GL. Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction. Proc Natl Acad Sci USA 1990: 87, 1937-1941.
35. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1982.
36. Martell KJ, Vatsis KP, Weber WW. Molecular genetic basis of rapid and slow acetylation in mice. Mol Pharmacol 1991: 40, 218-227.
37. Martell KJ, Levy GN, Weber WW. Cloned mouse N-acetyltransferases: Enzymatic properties of expressed NAT1 and NAT2 gene products. Mol Pharmacol 1992: 42, 265-272.
38. Nagata K, Ozawa S, Miyata M, Shimada M, Yamazoe Y, Kato R. Primary structure and molecular basis of polymorphic appearance of an acetyltransferase (AT-II) in hamsters. Pharmacogenetics 1994: 4, 91-100.
39. Norrander J, Kemper T, Messing J. Construction of improved M13 vectors by oligonucleotide-directed mutagenesis. Gene 1983: 26, 101-106.
40. Ogolla F, Ferguson RJ, Kirlin WG, Trinidad A, Andrews AF, Mpezo M, Hein DW. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian hamster intestine and colon: Identity with the hepatic acetylation polymorphism. Drug Metab Dispos 1990: 18, 680-685.
41. Ohsako S, Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 1990: 265, 4630-4633.
42. Ozawa S, Abu-Zeid M, Kawakubo Y, Toyama S, Yamazoe Y, Kato R. Monomorphic and polymorphic isozymes of arylamine N-acetyltransferases in hamster liver: purification of the isozymes and genetic basis of N-acetylation polymorphism. Carcinogenesis 1990: 11, 2137-2144.
43. Rogers JH. The origin and evolution of retroposons. Int Rev Cytol 1985: 93, 187-277.
44. Sanger F, Niklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977: 74, 5463-5467.
45. Sasaki YS, Ohsako S, Deguchi T. Molecular and genetic analyses of arylamine N-acetyltransferase polymorphism of rabbit liver. J Biol Chem 1991: 266, 13243-13250.
46. Smith TJ, Hanna PE. N-Acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes. Carcinogenesis 1986: 7, 697-702.
47. Trinidad A, Kirlin WG, Ogolla F, Andrews AF, Yerokun T, Ferguson RJ, Brady PK, Hein DW. Kinetic characterization of acetylator genotype-dependent and -independent N-aceiyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol. Drug Metab Dispos 1989: 17, 238-247.
48. Trinidad A, Hein DW, Rustan TD, Ferguson RJ, Miller LS, Bucher KD, Kirlin WG, Ogolla F, Andrews AF. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine O-acetyltransferase. Cancer Res 1990: 50, 7942-7949.
49. Vatsis KP, Weber WW, Bell DA, Dupret J-M, Evans DAP, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y. Nomenclature for N-acetyltransferases. Pharmacogenetics 1995: 5, 1-17.
50. Weber WW, Hein DW. N-acetylation pharmacogenetics. Pharmacol Rev 1985: 37, 25-79.
51. Yanisch-Perron C, Vieira J, Messing J. Improved M13 phagecloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985: 33, 103-119.
52. Yerokun T, Kirlin WG, Trinidad A, Ferguson RJ, Ogolla F, Andrews AF, Brady PK, Hein DW. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol. Drug Metab Dispos 1989: 17, 231-237.